Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1830)	8/3/2000 12:38:26 AM
From: scaram(o)uche	Respond to of 4974

Wednesday August 2, 8:32 pm Eastern Time Press Release SOURCE: Rosetta Inpharmatics, Inc. meanwhile...... August 1, 2000 VIA EXPRESS MAIL AND EDGAR Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549-0404 RE: Advanced Medicine, Inc. REGISTRATION STATEMENT ON FORM S-1 (FILE NO. 333-32990) Ladies and Gentlemen: Advanced Medicine, Inc. (the "Registrant") hereby requests (i) withdrawal of its Registration Statement on Form S-1, as amended to date (File No. 333-32990) (the "Registration Statement"), pursuant to Rule 477 of the Securities Act of 1933 and (ii) withdrawal of its application for confidential treatment of portions of an exhibit to the Registration Statement, which application was filed with the Commission on April 13, 2000. In light of unfavorable market conditions, the Registrant has determined at this time not to effect its initial public offering pursuant to the Registration Statement. The Registrant believes the withdrawal to be consistent with the public interest and the protection of investors. The Registrant represents that no securities have been offered or sold pursuant to the Registration Statement. Sincerely, ADVANCED MEDICINE, INC. /s/ James B. Tanabaum James B. Tanabaum President and Chief Executive Officer